News Regeneron, CytomX announce bispecific therapeutics for cance... Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc.
News Keenova eyes Xiaflex as first drug for plantar fibromatosis Keenova is hoping that its Xiaflex drug can become the first approved therapy for plantar fibromatosis, a debilitating condition affecting the feet.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
